Charles Schwab Investment Management Inc Pa Vmed Inc. Transaction History

Charles Schwab Investment Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$0.35 - $0.56 $27,826 - $44,521	79,503 New	79,503 $32,000
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.41 $141,423 - $234,595	-166,380 Reduced 85.25%	28,787 $27,000
Q1 2022 May 13, 2022	BUY	$1.16 - $2.5 $12,131 - $26,145	10,458 Added 5.66%	195,167 $258,000
Q4 2021 Feb 11, 2022	BUY	$2.46 - $8.74 $9,498 - $33,745	3,861 Added 2.13%	184,709 $455,000
Q3 2021 Nov 16, 2021	SELL	$5.1 - $9.39 $1,825 - $3,361	-358 Reduced 0.2%	180,848 $1.55 Million
Q2 2021 Aug 16, 2021	BUY	$3.95 - $6.88 $76,701 - $133,595	19,418 Added 12.0%	181,206 $1.16 Million
Q1 2021 May 17, 2021	BUY	$2.01 - $5.55 $169,907 - $469,147	84,531 Added 109.42%	161,788 $719,000
Q2 2020 Aug 14, 2020	BUY	$1.75 - $2.65 $135,199 - $204,731	77,257 New	77,257 $164,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $92.8M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.